Chemotherapy-Induced Nausea and Vomiting
Conditions
Interventions
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with breast cancer confirmed by pathology and meeting the chemotherapy indications; 2. Patients between 20 and 75 years old; 3. Patients whose chemotherapy regimens are mainly AC regimens or contain platinum; 4. Patients whose expected survival time is more than 6 months; 5. Patients with ECoG score 0-2; 6. The patients who voluntarily participated in the study signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe hepatic and renal insufficiency; 2. Patients with coagulation dysfunction, thrombocytopenia or bleeding related diseases; 3. Patients with refractory vomiting not caused by chemotherapy or existed before chemotherapy; 4. Patients with mental disorders; 5. Patients with hypotension; 6. Patients with edema, infection, ulceration or skin disease at acupuncture site; 7. Patients who feel dizzy, afraid of needling and blood sickness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of nausea and vomiting;Changes in serum 5-HT levels;TCM Syndrome Points; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital anxiety and depression scale; | — |
Countries
China
Contacts
Public ContactWan Donggui
China-Japan Friendship Hospital
Outcome results
None listed